Home > IVD Products > ImmunoAssays > Auto-Immunity > TRAb human > TRAb human RIA, 100 tests < you are here

TRAb human RIA, 100 tests

The DIAsource TRAb human kit is used for the quantitative determination of Thyro¬tropin (TSH) receptor autoantibodies in human serum. The majority of TSH receptor autoantibodies (TRAb) mimic the action of TSH on thyroid cells and thus increase blood levels of T4 and T3. Because they are not controlled by the negative feedback system, the stimulation of the thyroid gland often leads to the clinical thyrotoxic state of Graves’ disease. Consequently, the measurement of TRAb is valuable for the differential diagnosis of hyperthyroidism as well as for the follow-up of Graves' disease, both during and after its treatment by antithyroid drugs or 131-radioiodine or surgery. Pregnant women developing Graves' disease can transfer their autoantibodies to the fetus via the placental unit. The higher the TRAb concentrations of the mother, the greater the risk for the embryo to develop Graves' disease in uterus and thus to suffer from congenital hyperthyroidism

Catalog # KIPM2040
Format RIA
Label I125
Size 100 tests
Sample Type Serum
Sample Volume 100 µL
Controls 1 level
Range 0 - 50 IU/ml
Sensitivity 0,23 IU/ml
Incubation 120min./60 min.
Shelf Life (weeks) 7.5

Due to local registration requirement, this product can not be sold in Canada, United States, Australia – without prior registration.

For Japan and Brazil, specific registration requirements are necessary. For more information, please contact: RA@diasource.be.

Documents - Download
Download "Instructions for Use" KIPM2040.pdf
Download Brochure "Auto-Immunity" CATR.pdf
Coordinates

DIAsource ImmunoAssays SA
BE 0457.934.723
Rue du Bosquet, 2 | 1348 Louvain-la-Neuve - Belgium
Tel +32 10 84 99 11 | Fax +32 10 84 99 90

CLOSING DAYS 2019 : 1/01-22/04-01&30/05-10/06-21/07-15/08-01&11/11-25/12

Choose my country

DIAsource ImmunoAssays (formerly BioSource), experienced diagnostic manufacturer of RIA-ELISA-LIA immunoassays, validation on automates, large scale production of Antibodies-Point of Care Tests.

Please select your country to see the most accurate content available in your area.